ClinConnect ClinConnect Logo
Search / Trial NCT06236204

Arthroscopic Scapholunate Ligament Reconstruction

Launched by REGIONAAL ZIEKENHUIS HEILIG HART TIENEN · Jan 23, 2024

Trial Information

Current as of July 04, 2025

Not yet recruiting

Keywords

Scapholunate Instability Reconstruction

ClinConnect Summary

This clinical trial is looking at a specific surgical technique called arthroscopic reconstruction to treat a condition known as scapholunate dissociation. This condition happens when a key ligament in the wrist is completely injured, which can lead to pain and problems with wrist function. The study aims to find out how well this surgery works over time, focusing on both short-term and mid-term results for patients.

To participate in this trial, individuals need to be between the ages of 18 and 65 and have a specific type of wrist ligament injury that can be treated with this method. They should not have any other serious wrist injuries, arthritis, or neurological disorders affecting their upper limb. If eligible, participants will undergo the surgical procedure and will be monitored to assess their recovery and wrist function afterward. It's important to note that the trial is not yet recruiting participants, so there will be more information available once it opens.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Scapholunate dysfunction, complete irrepairable lesion of the SL ligament and the secondary stabilizers (RSC-LRL-SRL) EWAS stage 4-5, no arthritis, with reducible malalignment
  • 18 - 65 years
  • Exclusion Criteria:
  • - associated lesions, fractures
  • neurological disorder affecting the upper limb, history of wrist lesion involving the same wrist, dementia, substance abuse, severe psychiatric disorder and previous injured contralateral wrist

About Regionaal Ziekenhuis Heilig Hart Tienen

Regionaal Ziekenhuis Heilig Hart Tienen is a leading healthcare institution located in Tienen, Belgium, dedicated to providing high-quality medical care and fostering innovative clinical research. With a commitment to patient-centered services, the hospital integrates advanced medical practices and state-of-the-art facilities to enhance treatment outcomes. The institution actively engages in clinical trials across various therapeutic areas, aiming to contribute to the advancement of medical science and improve patient care. Through collaboration with healthcare professionals and research organizations, Regionaal Ziekenhuis Heilig Hart Tienen is at the forefront of translating research findings into effective clinical practices.

Locations

Tienen, , Belgium

Patients applied

0 patients applied

Trial Officials

Kjell Van Royen, MD

Study Chair

Universitair Ziekenhuis Brussel

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported